Turn this role into an interview — a resume and cover letter built around what this employer wants.
Leerink Partners LLC in New York seeks an Equity Research Associate focused on Targeted Oncology to support the healthcare investment team. The role involves collecting data, building financial models, and formulating investment ideas.
A BS/BA and biotech familiarity are required; prior consulting, pharma, or IB training is preferred. Strong Excel, quantitative and written/verbal communication skills are essential for drafting reports and interacting with executives and clients.
Job Title: Equity Research Associate – Targeted Oncology Reports to: Sr. Equity Research Analyst Department: Equity Research Location: New York Salary Range: $110,000-$135,000
Equal Employment Opportunity: Leerink Partners is an equal opportunity employer and is dedicated to expanding its commitments and investments to create a more diverse, equitable and inclusive company culture and innovation ecosystem. We are strongly committed to the values and policy of equal employment opportunity across our employment practices.
Actual starting base pay will be determined on skills, experience, and other non-discriminatory factors permitted by law. Total compensation may also include variable incentives, bonuses, benefits, and/or other perks, as outlined in any formal offer made. At Leerink Partners, we share a common desire to achieve the highest level of success for our clients. If you are passionate about healthcare and investing, our team has unmatched access to the necessary resources and support to leverage your talents and expertise into valuable contributions for our clients. Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and sales and trading capabilities. The firm's strategic focus on the healthcare industry empowers it to provide unique advice and insights to its clients. The firm is a broker-dealer registered with the United States Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority.